Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Ototoxicity × Clear all

Status

Sponsor Class

OTHER 15 INDUSTRY 3 NIH 2 OTHER_GOV 1 NETWORK 1 FED 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 241 Leukemia 159 Carcinoma, Non-Small-Cell Lung 154 Lymphoma 139 Lung Neoplasms 134 Prostatic Neoplasms 121 Precursor Cell Lymphoblastic Leukemia-Lymphoma 109 Colorectal Neoplasms 109 Ovarian Neoplasms 102 Sarcoma 100 Central Nervous System Neoplasms 95 Multiple Myeloma 88 Head and Neck Neoplasms 88 Leukemia, Myeloid, Acute 79 Squamous Cell Carcinoma of Head and Neck 77 Rectal Neoplasms 75 Colonic Neoplasms 66 Neoplasm Metastasis 62 Uterine Cervical Neoplasms 58 Carcinoma, Ovarian Epithelial 58 Brain Neoplasms 58 Fallopian Tube Neoplasms 57 Neuroblastoma 56 Melanoma 56 Neoplasms 54 Lymphoma, Large B-Cell, Diffuse 54 Astrocytoma 53 Hodgkin Disease 49 Leukemia, Lymphocytic, Chronic, B-Cell 48 Glioblastoma 48

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00458887 2017-03-13

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Children's Oncology Group

Ototoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡